Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00001120
What this trial is testing

Patients With AIDS Syndrome

Who this might be right for
Sarcoma, KaposiLymphoma, Non-HodgkinHIV Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT00552279
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 805
Early research (Phase 1)Study completedNCT04147234
What this trial is testing

Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)

Who this might be right for
Neoplasms
Boehringer Ingelheim 42
Not applicableStudy completedNCT00002026
What this trial is testing

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Who this might be right for
Leukoplakia, HairyHIV Infections
Glaxo Wellcome
Not applicableLooking for participantsNCT05573893
What this trial is testing

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Who this might be right for
Breast NeoplasmsBreast CancerNeoplasm Metastasis
AstraZeneca 800
Very early researchUnknownNCT04945499
What this trial is testing

The Application of Glucose CEST MR Imaging in Brain Tumor

Who this might be right for
Magnetic Resonance Imaging
Zhujiang Hospital 100
Early research (Phase 1)Study completedNCT02978755
What this trial is testing

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Who this might be right for
Neoplasm, Gynecologic
GamaMabs Pharma 78
Not applicableNot Yet RecruitingNCT07645378
What this trial is testing

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

Who this might be right for
HIV (Human Immunodeficiency Virus)HPVCervical Precancer+1 more
Fred Hutchinson Cancer Center 200
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Early research (Phase 1)Ended earlyNCT02240758
What this trial is testing

Confocal Laser Endomicroscopy for Brain Tumors

Who this might be right for
Low Grade Glioma (LGG), High Grade Glioma (HGG)
Hospices Civils de Lyon 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487
What this trial is testing

NDI 1150-101 in Patients With Solid Tumors

Who this might be right for
Solid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Nimbus Saturn, Inc. 106
Early research (Phase 1)Study completedNCT01469052
What this trial is testing

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 36
Testing effectiveness (Phase 2)Looking for participantsNCT06564038
What this trial is testing

AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle-cell Lymphoma+2 more
AstraZeneca 408
Not applicableStudy completedNCT01271738
What this trial is testing

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+4 more
Emory University 79
Early research (Phase 1)Study completedNCT01005355
What this trial is testing

Study of IMC-1121B in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 15
Large-scale testing (Phase 3)Study completedNCT00264732
What this trial is testing

Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix

Who this might be right for
Uterine Cervical Dysplasia
Eisai Inc. 251
Testing effectiveness (Phase 2)Looking for participantsNCT07735104
What this trial is testing

The First in Human Study of QLS2319 in Healthy Subjects and Cancer Cachexia

Who this might be right for
Cancer CachexiaCancer Cachexia Syndrome
Qilu Pharmaceutical Co., Ltd. 88
Testing effectiveness (Phase 2)Looking for participantsNCT07805252
What this trial is testing

Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer

Who this might be right for
Advanced Solid Tumors Cancer
Orion Corporation, Orion Pharma 195
Next Page